News & Events - Inventiva Pharma

News & Events

Inventiva to participate at the SVB Leerink CybeRx Series: Liver Disease Day

Inventiva announces three scientific presentations at the EASL International Liver Congress™ 2021 and during a KOL webcast event

Inventiva to participate at the Jefferies Virtual Healthcare Conference

Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseases

Inventiva to participate at the 7th Annual Truist Securities Life Sciences Summit

Appointment of Martine Zimmermann as Independent Director to Inventiva’s Board of Directors

Shareholders Meeting of April 16, 2021 – Availability of the preparatory documents and methods for participating and voting

Inventiva announces filing of its 2020 Universal Registration Document and 2020 Annual Report on Form 20-F

2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States

Load More

Upcoming Investors Meetings

Upcoming Science Conferences

Questions?
Get in touch!

Inventiva
Frédéric Cren
Chief Executive Officer
info@inventivapharma.com
+33 3 80 44 75 00

Brunswick
Yannick Tetzlaff / Tristan Roquet Montegon / Aude Lepreux
Media relations
inventiva@brunswickgroup.com
+33 1 53 96 83 83

Patti Bank
Managing Director
ICR Westwicke
Patti.Bank@westwicke.com
D 415-513-1284
San Francisco, CA
www.westwicke.com